KIN-213

N/A

Report date: 2025/01/26 17:15:49
NME

Base Information

Drug NameKIN-213
Drug Alias NameKinnear-213KIN-213
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCystic FibrosisRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKinnear Pharmaceuticals LLC
China Registration ClassN/A

Develop Information

Active CompaniesKinnear Pharmaceuticals LLC
Inactive CompaniesN/A
Active IndicationsCystic FibrosisRespiratory Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A